Envoy Medical (COCHW) Return on Sales (2022 - 2026)

Envoy Medical's Return on Sales history runs 5 years deep, the most recent figure standing at 1.53% for Q1 2026.

• In Q1 2026, Return on Sales fell 31.0% year-over-year to 1.53%; the TTM figure through Mar 2026 stood at 1.03% (down 6.0% YoY), while the FY2025 annual figure was 0.99%, down 10.0% from the prior year.
• Return on Sales came in at 1.53% for Q1 2026 at Envoy Medical, down from 0.85% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 1.0% in Q3 2022 to a low of 1.53% in Q1 2026.
• A 5-year average of 0.7% and a median of 0.83% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales sank 142 bps in 2023 and jumped 32 bps in 2025, its largest moves.
• Envoy Medical's Return on Sales stood at 0.84% in 2022, then grew by 16 bps to 0.71% in 2023, then slumped by 66 bps to 1.17% in 2024, then climbed by 28 bps to 0.85% in 2025, then plunged by 79 bps to 1.53% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 1.53%, 0.85%, and 1.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison